If you’ve relied on pharmacy discount cards like GoodRx, SingleCare, or Optum Perks to save on prescriptions, you likely noticed a shift in your January 2026 receipts. While these cards are still legal and widely accepted, the “deep discounts” of the past are becoming harder to secure at national chains like CVS, Walgreens, and Walmart. This is the result of a massive industry “realignment”: as Medicare’s new $2,000 out-of-pocket cap takes effect this month, pharmacies are trimming third-party discount programs to protect their shrinking profit margins.
1. The “Medicare Cap” Revenue Squeeze
The primary driver of shrinking discounts is the Inflation Reduction Act’s $2,000 annual out-of-pocket cap for Part D beneficiaries. Because insurance companies are now on the hook for 100% of drug costs after a senior spends $2,000, they have aggressively renegotiated their contracts with pharmacies. To stay profitable under these lower reimbursement rates, major chains are reducing the “spread” they allow for third-party discount cards, leading to higher prices for customers who shop outside their insurance.
2. The Move to “Post-Purchase” Rebates
Starting in January 2026, many drugs—particularly those with negotiated “Maximum Fair Prices”—are moving from upfront discounts to a “Post-Purchase Rebate” model. Pharmacies now have to pay the full wholesale price upfront and wait for a rebate later. This creates a cash-flow crunch that makes them less willing to accept third-party discount codes that slash their immediate revenue.
3. Pushing “In-House” Loyalty Programs
National chains are increasingly blocking outside cards to funnel customers into their own paid “loyalty” tiers. Programs like Walgreens’ Prescription Savings Club (which requires an annual fee) or CVS’s ExtraCare Pharmacy & Health Rewards are often the only way to get “rock-bottom” pricing. This forces seniors into a “subscription” model for their health, where they must pay for a membership just to access the discounted generic prices they used to get for free.
4. The Block on “Blockbuster” Drugs
The most significant shrinkage in 2026 is seen in high-demand medications. While generic blood pressure pills still see discounts, discount programs are increasingly restricted for GLP-1s (like Ozempic and Wegovy) and new oncology treatments. Many national chains have simply “opted out” of allowing discount cards for these high-cost items, forcing patients to either use insurance or pay the full cash price.
How to Find Savings in 2026
The pharmacy landscape of 2026 is no longer a one-size-fits-all market. While national chains are pulling back, many independent and rural pharmacies—vulnerable but eager for business—are still enrolled in discount programs to attract new patients. If your local CVS price has spiked, check the GoodRx or SingleCare app for an independent pharmacy nearby. Additionally, consider the Medicare Prescription Payment Plan, which allows you to spread your out-of-pocket costs over the year, making your budget much more predictable.
Have you noticed your favorite discount card is saving you less this month? Leave a comment below—we’re tracking which 2026 programs are still worth the download.
You May Also Like…
5 Pharmacy Pricing Adjustments That Appear After Refill History Updates
A New Round of Pharmacy Closures Is Hitting Retirement Areas Hard
Pharmacies Are Requiring More Frequent Renewals for Senior Prescriptions
Discount Pharmacies Are Running Out of Key Senior Medications
An Increase in Prescription Verifications Is Slowing Down Pharmacy Lines
